Bryan Dechairo Envisions an Accessible Future for CRISPR Diagnostics

from CRISPR Cuts · host Synthego

In this episode, Bryan Dechairo, CEO of Sherlock Biosciences, talks about the impact of technology advances in the field of CRISPR diagnostics, his experiences leading Sherlock Biosciences, and his team’s mission of accessibility.

Episode metadata supplied by the publisher feed · Published Sep 6, 2022

Embed this episode

Attribution link and audio player

Ready to play

Bryan Dechairo Envisions an Accessible Future for CRISPR Diagnostics

0:00 35:29

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of CRISPR Cuts?

This episode is 35 minutes long.

When was this CRISPR Cuts episode published?

This episode was published on September 6, 2022.

Can I download this CRISPR Cuts episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!